Investigating how cell death proteins affect inflammation in sepsis
Cell death proteins as inflammatory mediators in sepsis
This study is looking at how certain cell signals related to cell death affect inflammation in people with sepsis, a serious infection, to help find better treatments for those who are suffering from it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11094066 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of cell death signaling pathways in the inflammatory response associated with sepsis, a severe condition triggered by infection. By analyzing samples from septic patients, the study aims to uncover how these pathways contribute to inflammation and tissue damage. The research employs both laboratory techniques and patient data to explore the mechanisms behind sepsis, which could lead to the development of targeted therapies. The ultimate goal is to improve treatment options for patients suffering from this critical illness.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with sepsis or those at high risk of developing sepsis due to severe infections.
Not a fit: Patients with non-infectious causes of critical illness or those not experiencing sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new targeted therapies for sepsis, improving patient outcomes and reducing mortality rates.
How similar studies have performed: Previous research has shown promise in understanding inflammatory responses in sepsis, but this specific approach focusing on cell death proteins is relatively novel.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Lyons, John Daniel — Emory University
- Study coordinator: Lyons, John Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.